KORY JAMES WENTWORTH, CAO at Bluebird Bio, holds 83.17K shares in Entrada Therapeutics Inc (Ticker: TRDA), holds 9.51K shares in Bluebird Bio (Ticker: BLUE). Most recently, KORY JAMES WENTWORTH Bought ― shares of Entrada Therapeutics Inc on Mar 19, 2024 for an estimated value of 18.90K.